Allosteric modulation of alternatively spliced Ca<sup>2+</sup>-activated Cl<sup>-</sup> channels TMEM16A by PI(4,5)P<sub>2</sub> and CaMKII.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33199590.
- Also identified by DOI 10.1073/pnas.2014520117 and PMC identifier 7720229.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transmembrane 16A (TMEM16A, anoctamin1), 1 of 10 TMEM16 family proteins, is a Cl<sup>-</sup> channel activated by intracellular Ca<sup>2+</sup> and membrane voltage. This channel is also regulated by the membrane phospholipid phosphatidylinositol 4,5-bisphosphate [PI(4,5)P<sub>2</sub>]. We find that two splice variants of TMEM16A show different sensitivity to endogenous PI(4,5)P<sub>2</sub> degradation, where TMEM16A(ac) displays higher channel activity and more current inhibition by PI(4,5)P<sub>2</sub> depletion than TMEM16A(a). These two channel isoforms differ in the alternative splicing of the c-segment (exon 13). The current amplitude and PI(4,5)P<sub>2</sub> sensitivity of both TMEM16A(ac) and (a) are significantly strengthened by decreased free cytosolic ATP and by conditions that decrease phosphorylation by Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII). Noise analysis suggests that the augmentation of currents is due to a rise of single-channel current (<i>i</i>), but not of channel number (<i>N</i>) or open probability (<i>P</i><sub>O</sub>). Mutagenesis points to arginine 486 in the first intracellular loop as a putative binding site for PI(4,5)P<sub>2</sub>, and to serine 673 in the third intracellular loop as a site for regulatory channel phosphorylation that modulates the action of PI(4,5)P<sub>2</sub> In silico simulation suggests how phosphorylation of S673 allosterically and differently changes the structure of the distant PI(4,5)P<sub>2</sub>-binding site between channel splice variants with and without the c-segment exon. In sum, our study reveals the following: differential regulation of alternatively spliced TMEM16A(ac) and (a) by plasma membrane PI(4,5)P<sub>2</sub>, modification of these effects by channel phosphorylation, identification of the molecular sites, and mechanistic explanation by in silico simulation.
Medical subject headings
- Alternative Splicing
- Anoctamin-1
- Calcium-Calmodulin-Dependent Protein Kinase Type 2
- Phosphatidylinositols